https://www.eurekalert.org/pub_releases/2020-10/aaft-iso102820.php
News Release 28-Oct-2020
American Association for the Advancement of Science
Researchers who studied antibody responses in 30,000 patients with mild-to-moderate COVID-19 report that the patients' antibodies were relatively stable for at least five months. Although the results do not yet provide conclusive evidence that these levels protect from reinfection, Ania Wajnberg and colleagues say they "believe it is very likely that they will decrease the odds ratio of reinfection and may attenuate disease in the case of breakthrough infection."
•••••
No comments:
Post a Comment